TNFRSF8 anticorps
-
- Antigène Voir toutes TNFRSF8 Anticorps
- TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8))
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp TNFRSF8 est non-conjugé
-
Application
- Immunohistochemistry (IHC), ELISA
- Réactivité croisée
- Humain
- Purification
- Antigen affinity purification
- Immunogène
- Synthetic peptide of Human TNFRSF8
- Isotype
- IgG
- Top Product
- Discover our top product TNFRSF8 Anticorps primaire
-
anti-Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8) (AA 19-379) antibody
TNFRSF8 Reactivité: Humain IHC, WB, IHC (p) Hôte: Souris Monoclonal 18D3 unconjugated
anti-Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8) antibodyTNFRSF8 Reactivité: Humain FACS, WB, ELISA Hôte: Souris Monoclonal 3B10 unconjugated
anti-Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8) antibodyTNFRSF8 Reactivité: Humain, Souris, Rat IHC, IF Hôte: Lapin Polyclonal unconjugated
anti-Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8) (AA 19-379) antibodyTNFRSF8 Reactivité: Humain FACS, IHC, WB, ELISA, ICC, Neut Hôte: Souris Monoclonal 4D1C2 unconjugated
anti-Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8) antibodyTNFRSF8 Reactivité: Humain FACS, IHC (p) Hôte: Souris Monoclonal MEM-268 unconjugated
anti-Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8) (AA 131-230) antibodyTNFRSF8 Reactivité: Humain, Porc FACS, WB, IHC (p), ELISA, IF (p), IF (cc), IHC (fro) Hôte: Lapin Polyclonal unconjugated
anti-Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8) antibody (APC)TNFRSF8 Reactivité: Humain FACS Hôte: Souris Monoclonal MEM-268 APC
anti-Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8) antibodyTNFRSF8 Reactivité: Humain IF, WB Hôte: Lapin Monoclonal unconjugated
anti-Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8) antibodyTNFRSF8 Reactivité: Humain FACS, WB, IHC (p), IP Hôte: Souris Monoclonal Ber-H2 unconjugated
anti-Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8) antibodyTNFRSF8 Reactivité: Humain FACS, IHC (p), IHC (fro) Hôte: Souris Monoclonal Ber-H8 unconjugated
-
- Indications d'application
- ELISA:1:2000-1:10000, IHC:1:100-1:300,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- -20 °C, pH 7.4 PBS, 0.05 % Sodium azide, 40 % Glycerol
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8))
- Autre désignation
- TNFRSF8 (TNFRSF8 Produits)
- Synonymes
- anticorps CD30, anticorps D1S166E, anticorps Ki-1, anticorps Cd30, anticorps Ki, anticorps TNFRSF8, anticorps TNF receptor superfamily member 8, anticorps tumor necrosis factor receptor superfamily, member 8, anticorps TNFRSF8, anticorps Tnfrsf8
- Sujet
-
Background: The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is expressed by activated, but not by resting, T and B cells. TRAF2 and TRAF5 can interact with this receptor, and mediate the signal transduction that leads to the activation of NF-kappaB. This receptor is a positive regulator of apoptosis, and also has been shown to limit the proliferative potential of autoreactive CD8 effector T cells and protect the body against autoimmunity. Two alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported.
Aliases: CD 30 antibody, CD30 antibody, CD30 antigen antibody, CD30L receptor antibody, Cytokine receptor CD30 antibody, D1S166E antibody, KI 1 antibody, KI 1 antigen antibody, Ki-1 antigen antibody, KI1 antibody, Lymphocyte activation antigen CD30 antibody, TNFRSF 8 antibody, Tnfrsf8 antibody, TNR8_HUMAN antibody, Tumor necrosis factor receptor superfamily member 8 antibody
- UniProt
- P28908
-
